Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Evaluating the efficacy of cancer screening: clinical distinctions and case-control studies.

Gill TM, Horwitz RI.

J Clin Epidemiol. 1995 Feb;48(2):281-92.

PMID:
7869074
2.

Population-based case-control study on cancer screening.

Sobue T, Suzuki T, Fujimoto I, Yokoi N, Naruke T.

Environ Health Perspect. 1990 Jul;87:57-62.

3.

Screening for skin cancer.

Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT.

Am J Prev Med. 2001 Apr;20(3 Suppl):47-58. Review.

PMID:
11306232
4.

The case-control design and the assessment of the efficacy of cancer screening.

Connor RJ, Prorok PC, Weed DL.

J Clin Epidemiol. 1991;44(11):1215-21.

PMID:
1941016
5.

Case-control studies for the evaluation of screening.

Sasco AJ, Day NE, Walter SD.

J Chronic Dis. 1986;39(5):399-405.

PMID:
3700581
6.

Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome.

Weiss NS, Lazovich D.

Am J Epidemiol. 1996 Feb 15;143(4):319-22. Review. No abstract available.

PMID:
8633615
7.

Patient follow up screening evaluations. Examples with regard to congenital hip dislocation and congenital heart disease.

Juttmann RE, Hess J, van Oortmarssen GJ, van der Maas PJ.

J Epidemiol Community Health. 2001 Feb;55(2):126-31.

8.

The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan.

Sagawa M, Nakayama T, Tsukada H, Nishii K, Baba T, Kurita Y, Saito Y, Kaneko M, Sakuma T, Suzuki T, Fujimura S.

Lung Cancer. 2003 Jul;41(1):29-36.

PMID:
12826309
9.

Interview-based case-control studies of screening efficacy.

Weiss NS, Bodelon C.

Epidemiology. 2008 Mar;19(2):265-7. doi: 10.1097/EDE.0b013e3181632c8c. Review.

PMID:
18277161
10.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
11.
12.

Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.

Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E.

Cancer. 2000 Feb 1;88(3):664-73.

PMID:
10649262
13.

Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.

Inadomi JM.

J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x.

PMID:
19120898
14.

The effectiveness of screening for prostate cancer: a nested case-control study.

Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, Froehlich G, Blake D, Vickers MA, Gehr GA, Raheb NH, Sullivan G, Peduzzi P.

Arch Intern Med. 2006 Jan 9;166(1):38-43.

PMID:
16401808
15.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

16.

A population-based case-cohort evaluation of the efficacy of mammographic screening for breast cancer.

Thompson RS, Barlow WE, Taplin SH, Grothaus L, Immanuel V, Salazar A, Wagner EH.

Am J Epidemiol. 1994 Nov 15;140(10):889-901.

PMID:
7977276
17.

Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.

Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M, Takahashi Y, Suzuki T, Yamanda T, Kondo R, Hanaoka T, Takayama F, Kubo K, Fushimi H.

Lung Cancer. 2007 Dec;58(3):329-41. Epub 2007 Aug 6.

PMID:
17675180
18.

Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.

Godley PA, Carpenter WR.

J Clin Epidemiol. 2007 Feb;60(2):176-80. Epub 2006 Sep 28.

PMID:
17208124
20.

A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.

Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW.

J Med Screen. 2004;11(4):194-8.

PMID:
15563774

Supplemental Content

Support Center